Most recent

ISO 18362:2016

Manufacture of cell-based health care products - Control of microbial risks during processing


ISO 18362:2016 specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled 'sterile' and to CBHPs not labelled 'sterile'.

ISO 18362:2016 is not applicable to:

- procurement and transport of cell-based starting material used in processing of a CBHP,

- cell banking,

- control of genetic material,

- control of non-microbial product contamination,

- in vitro diagnostics (IVDs), or

- natural medicines.

EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids.

ISO 18362:2016 does not define biosafety containment requirements.

ISO 18362:2016 does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.


CONTENT PROVIDER
International Organization for Standardization [iso]

Others Also Bought
Aseptic processing of health care products - Part 1: General requirements
Cleanrooms and associated controlled environments - Part 4: Design, construction and start-up
Cleanrooms and associated controlled environments - Part 3: Test methods
Document History
We have no document history for this standard.
Included in Packages
This standard is not included in any packages.
Amendments & Corrections